Menu
Log in
Forgot password
Log in
Forgot password

News

  • Home
  • Resources
  • Literature Updates
  • Evaluation of the Association of Perioperative UGT1A1 Genotype–Dosed gFOLFIRINOX With Margin-Negative Resection Rates and Pathologic Response Grades Among Patients With Locally Advanced Gastroesophageal Adenocarcinoma A Phase 2 Clinical Trial

Evaluation of the Association of Perioperative UGT1A1 Genotype–Dosed gFOLFIRINOX With Margin-Negative Resection Rates and Pathologic Response Grades Among Patients With Locally Advanced Gastroesophageal Adenocarcinoma A Phase 2 Clinical Trial

26 Feb 2020 2:33 AM | Deleted user

Daniel V. T. Catenacci, Leah Chase, Samantha Lomnicki, Theodore Karrison, Robert de Wilton Marsh, Murtuza M. Rampurwala, Sunil Narula, Lindsay Alpert, Namrata Setia, Shu-Yuan Xiao, John Hart, Uzma D. Siddiqui, Bryan Peterson, Kelly Moore, Kristin Kipping-Johnson, Ugne Markevicius, Barbara Gordon, Kenisha Allen, Christine Racette, Steven B. Maron, Chih-Yi Liao, Blase N. Polite, Hedy L. Kindler, Kiran Turaga, Vivek N. Prachand, Kevin K. Roggin, Mark K. Ferguson, Mitchell C. Posner.

Click here to read the full abstract.

Affiliated Societies



International  Interdisciplinary  Everything Esophageal


The International Society for Diseases of the Esophagus is a 501(c)3 non-profit organization. © International Society for Disease of the Esophagus – ISDE 2024 | Any unauthorized use or reproduction of the content is prohibited without explicit permission.

General Inquiries: info@isde.net
Membership Questions: membership@isde.net

Powered by Wild Apricot Membership Software